Changes in use of psychostimulant medication for ADHD in South Australia (1990–2006)

References

• National Health and Medical Research Council Attention deficit hyperactivity disorder (ADHD). Canberra: NH&MRC, 1996.
   Google Scholar
• Angold A, Erkanli A, Egger H, Costello J. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 2000; 39: 975–984
   PubMed Web of Science ®Google Scholar
• LeFever G, Dawson KV, Morrow AL. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health 1999; 89: 1359–1364
   PubMed Web of Science ®Google Scholar
• Reid R, Maag JW, Vasa SF, Wright G. Who are the children with ADHD: a school-based survey. J Spec Educ 1994; 28: 117–137
   Web of Science ®Google Scholar
• Wolraich ML, Lindgren S, Stromquist A, Milich R, Davis C, Watson D. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 1990; 86: 95–101
   PubMed Web of Science ®Google Scholar
• Greenhill LL. Practice parameters for the use of stimulant medication in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry 2002; 41: 26S–49S
   PubMed Web of Science ®Google Scholar
• Crenshaw TM, Kavale KA, Forness SR, Reeve RE. Attention deficit hyperactivity disorder and the efficacy of stimulant medication: a metaanalysis. Advances in learning and behavioral disabilities, T Scruggs, M Mastropieri. JAI, Greenwich, CT 1999; 13: 135–165
   Google Scholar
• MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56:1073–1086.
   Google Scholar
• MTA Cooperative Group National Institute of Mental Health Multimodal Treatment Study of ADHD follow up: changes in effectiveness and growth after treatment. Pediatrics 2004; 113:762–770.
   PubMed Web of Science ®Google Scholar
• Prosser BJ, Reid R. Psychostimulant use for children with attention deficit hyperactivity disorder in Australia. J Emot Behav Disord 1999; 7: 110–117
   Web of Science ®Google Scholar
• Prosser BJ. ADHD: who's failing who?. Finch Publishing, Lane Cove, NSW 2006
   Google Scholar
• Drug Enforcement Agency, Office of Congressional and Public Affairs Controlled substances: aggregate production quotas (1989–1998). Washington, DC: U.S. Department of Justice, 1998.
   Google Scholar
• Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med 1995; 333: 944
   PubMed Web of Science ®Google Scholar
• Safer DJ, Krager JM. A survey of medication treatment for hyperactive/inattentive students. JAMA 1988; 260: 2256–2258
   PubMed Web of Science ®Google Scholar
• Robison L, Sclar D, Skaer T, Galin R. National trends in the prevalence of attention-deficit hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990–1995. Clin Pediatr 1999; 38: 209–217
   PubMed Web of Science ®Google Scholar
• Conners CK. Attention-deficit/hyperactivity disorder: historical development and overview. J Atten Disord 2000; 3: 173–191
   Google Scholar
• Centers for Disease Control and Prevention (2005) Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder–United States, 2003. Morbid Mortal Wkly Rep ; 54:842–847.
   Google Scholar
• Centers for Disease Control and Prevention Prevalence of diagnosis and medical treatment for attention-deficit/hyperactivity disorder. JAMA 2005; 294:2293–2295.
   Web of Science ®Google Scholar
• Neufeld P, Foy M. Historical reflections on the ascendancy of ADHD in North America c. 1980–c.2005. Br J Educ Stud 2006; 54: 449–470
   Web of Science ®Google Scholar
• Morrow RC, Morrow AL, Haislip G. Methylphenidate in the United States, 1990 through 1995. Am J Public Health 1998; 88: 1121
   PubMed Web of Science ®Google Scholar
• Gadow KG. Prevalence of drug treatment for hyperactivity and other childhood behavior disorders. Psychosocial aspects of drug treatment for hyperactivity, KG Gadow, J Loney. Westview Press, Boulder, CO 1981; 13–76
   Google Scholar
• Sherman M, Hertzig ME. Prescribing practices of Ritalin: the Suffolk County, New York study. Ritalin theory and patient management, LL Greenhill, BB Osman. MA Liebert, Larchmont, NY 1991; 187–194
   Google Scholar
• Shaywitz SE, Shaywitz BA. Attention deficit disorder: current perspectives. Learning disabilities: proceedings of the national conference, JG Kavanagh, TJ Truss, Jr. New York Press, Parkton 1988; 69–523
   Google Scholar
• Safer DJ, Zito JM. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. Ritalin: Theory and practice2nd edn, L Greenhill, B Osman. Liebert, Larchmont, NY 2000; 7–26
   Google Scholar
• Berbatis CG, Sunderland VB, Bulsara M. Licit psychostimulant consumption in Australia, 1984–2000: international and jurisdictional comparisons. Med J Aust 2002; 177: 539–543
   PubMed Web of Science ®Google Scholar
• Calver J, Preen D, Blusara M, Sanfilippo F. Stimulant prescribing for the treatment of ADHD in Western Australia: socioeconomic and remoteness differences. Med J Aust 2007; 186: 124–127
   PubMed Web of Science ®Google Scholar
• Commonwealth of Australia Issues brief 11 2000–2001: medication for AD/HD – an analysis by federal electorate. Canberra: Australian Parliamentary Library, 2001.
   Google Scholar
• Commonwealth of Australia Issues brief 8 2004–2005: medication for AD/HD. Canberra: Australian Parliamentary Library, 2004.
   Google Scholar
• Reid R, Hakendorf P, Prosser BJ. Use of psychostimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 2002; 41: 1–8
   Web of Science ®Google Scholar
• Rappley MD, Gardiner JC, Jetton JR, Houang RT. The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 1995; 149: 675–679
   PubMed Web of Science ®Google Scholar
• Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA. Methylphenidate patterns among Medicaid youth. Psychopharmacol Bull 1997; 33: 143–147
   PubMedGoogle Scholar
• Szatmari P, Offord DR, Boyle MH. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry 1989; 30: 219–230
   PubMed Web of Science ®Google Scholar
• Safer DJ, Krager JM. The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics 1994; 94: 462–464
   PubMed Web of Science ®Google Scholar
• Biederman J, Milberger S, Faraone SV, et al. Family-environment risk factors for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52: 464–470
   PubMed Web of Science ®Google Scholar
• Murphy JM, Wehler C, Pagano MA, Little M, Kleinman RE, Jellinek MS. Relationship between hunger and psychosocial functioning in low-income American children. J Am Acad Child Adolesc Psychiatry 1998; 37: 163–170
   PubMed Web of Science ®Google Scholar
• Stevens G. Bias in the attribution of hyperkinetic behavior as a function of ethnic identification and socioeconomic status. Psychol Sch 1981; 18: 99–106
   Web of Science ®Google Scholar
• Bussing R, Zima BT, Perwein AR, Belin TR, Widawski M. Children in special education: attention deficit hyperactivity disorder, use of services and unmet need. Am J Public Health 1998; 88: 880–886
   PubMed Web of Science ®Google Scholar
• Diller LH. Running on Ritalin: a physician reflects on children, society and performance in a pill. Bantam Books, New York 1998
   Google Scholar
• Prosser B, Reid R, Shute R, Atkinson I. Attention deficit hyperactivity disorder: special education policy and practice in Australia. Aust J Educ 2002; 46: 65–78
   Google Scholar
• Bussing R, Schoenberg NE, Rogers KM, Zima BT, Angus S. Explanatory models of ADHD: do they differ by ethnicity, child gender, or treatment status?. J Emot Behav Disord 1998; 6: 233–242
   Web of Science ®Google Scholar
• Efron D. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (Against). J Paediatr Child Health 2006; 42: 548–551
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Management Agency New Zealand Annual review. Wellington, NZ: PHARMAC, 2003.
   Google Scholar
• Mackey P, Kopras A. Medication for attention deficit hyperactivity disorder (ADHD): an analysis by federal electorate. Australian Federal Parliament, Canberra 2001
   Google Scholar
• Australian Bureau of Statistics Index of relative socio-economic advantage/disadvantage. Belconnen, ACT: Commonwealth of Australia, 2007.
   Google Scholar
• Barbaresi W, Katusic S, Colligan R, Weaver A, Leibson C, Jacobson S. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. Dev Behav Pediatr 2006; 27: 1–10
   PubMed Web of Science ®Google Scholar
• Taylor M, O'Donoghue T, Houghton S. To medicate or not to medicate? The decision-making process of Western Australian parents following their child's diagnosis with an attention deficit hyperactivity disorder. Int J Disabil Dev Educ 2006; 53: 111–128
   Google Scholar
• Bussing R, Zima B, Mason D, Hou W, Garvan C, Forness S. Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2005; 15: 78–87
   PubMed Web of Science ®Google Scholar
• Carpenter L, Austin H. How to be recognized enough to be included?. Int J Incl Educ 2008; 12: 35–48
   Web of Science ®Google Scholar
• Graham L. From ABCs to ADHD: the implication of schooling in the construction of ‘behaviour disorder’ and production of ‘disorderly subjects’. Int J Incl Educ 2008; 12: 7–33
   Web of Science ®Google Scholar
• Prosser BJ. Beyond ADHD: a consideration of attention deficit hyperactivity disorder and pedagogy in Australian schools. Intl J Incl Educ 2008; 12: 81–97
   Web of Science ®Google Scholar
• Sawyer M, Rey J, Arney F, Whitham J, Clark J, Baghurst P. Use of health and school-based services in Australia by young people with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2004; 43: 1355–1363
   PubMed Web of Science ®Google Scholar
• Hoagwood K, Kelleher KJ, Feil M, Comer D. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 2000; 39: 198–206
   PubMed Web of Science ®Google Scholar